Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values. - Dataset (ID:20364)
Download: Excel (XLSX), Comma-separated (CSV)
Cell line | Drug name | Experimental replicate | Timepoint | Drug concentration | Live cell count | Average live cell count, DMSO control | Average live cell count (time = 0) | Log10(drug concentration) | GR value | Relative cell count (treatment versus DMSO) | Cell doublings (DMSO control) | Experiment name |
---|---|---|---|---|---|---|---|---|---|---|---|---|
HCC1806 | Pictilisib | 2 | 72 | 3.2 | 8798.5 | 11984.0 | 1643.3 | 0.505 | 0.796 | 0.734 | 2.866 | HCC1806 GDC0941 0 2 72 |
HCC1806 | GDC-0980 | 2 | 72 | 0.001 | 11516.0 | 11293.0 | 1643.3 | -3.0 | 1.010 | 1.020 | 2.781 | HCC1806 GDC0980 0 2 72 |
HCC1806 | GDC-0980 | 2 | 72 | 0.0032 | 11217.3 | 11293.0 | 1643.3 | -2.49 | 0.995 | 0.993 | 2.781 | HCC1806 GDC0980 0 2 72 |
HCC1806 | GDC-0980 | 2 | 72 | 0.01 | 11207.3 | 11293.0 | 1643.3 | -2.0 | 0.995 | 0.992 | 2.781 | HCC1806 GDC0980 0 2 72 |
HCC1806 | GDC-0980 | 2 | 72 | 0.032 | 11461.8 | 11293.0 | 1643.3 | -1.49 | 1.010 | 1.010 | 2.781 | HCC1806 GDC0980 0 2 72 |
HCC1806 | GDC-0980 | 2 | 72 | 0.1 | 10419.3 | 11293.0 | 1643.3 | -1.0 | 0.943 | 0.923 | 2.781 | HCC1806 GDC0980 0 2 72 |
HCC1806 | GDC-0980 | 2 | 72 | 0.32 | 7985.5 | 11293.0 | 1643.3 | -0.495 | 0.766 | 0.707 | 2.781 | HCC1806 GDC0980 0 2 72 |
HCC1806 | GDC-0980 | 2 | 72 | 1.0 | 5800.0 | 11293.0 | 1643.3 | 0.0 | 0.574 | 0.514 | 2.781 | HCC1806 GDC0980 0 2 72 |
HCC1806 | GDC-0980 | 2 | 72 | 3.2 | 3828.3 | 11293.0 | 1643.3 | 0.505 | 0.355 | 0.339 | 2.781 | HCC1806 GDC0980 0 2 72 |
HCC1806 | Omipalisib | 2 | 72 | 0.001 | 10878.5 | 11840.0 | 1643.3 | -3.0 | 0.941 | 0.919 | 2.849 | HCC1806 GSK458 0 2 72 |
HCC1806 | Omipalisib | 2 | 72 | 0.0032 | 11552.0 | 11840.0 | 1643.3 | -2.49 | 0.983 | 0.976 | 2.849 | HCC1806 GSK458 0 2 72 |
HCC1806 | Omipalisib | 2 | 72 | 0.01 | 10689.3 | 11840.0 | 1643.3 | -2.0 | 0.929 | 0.903 | 2.849 | HCC1806 GSK458 0 2 72 |
HCC1806 | Omipalisib | 2 | 72 | 0.032 | 7012.3 | 11840.0 | 1643.3 | -1.49 | 0.664 | 0.592 | 2.849 | HCC1806 GSK458 0 2 72 |
HCC1806 | Omipalisib | 2 | 72 | 0.1 | 4476.3 | 11840.0 | 1643.3 | -1.0 | 0.422 | 0.378 | 2.849 | HCC1806 GSK458 0 2 72 |
HCC1806 | Omipalisib | 2 | 72 | 0.32 | 3470.8 | 11840.0 | 1643.3 | -0.495 | 0.300 | 0.293 | 2.849 | HCC1806 GSK458 0 2 72 |
HCC1806 | Omipalisib | 2 | 72 | 1.0 | 1813.3 | 11840.0 | 1643.3 | 0.0 | 0.035 | 0.153 | 2.849 | HCC1806 GSK458 0 2 72 |
HCC1806 | Omipalisib | 2 | 72 | 3.2 | 569.3 | 11840.0 | 1643.3 | 0.505 | -0.311 | 0.048 | 2.849 | HCC1806 GSK458 0 2 72 |
HCC1806 | KIN001-244 | 2 | 72 | 0.001 | 11912.3 | 11660.3 | 1643.3 | -3.0 | 1.020 | 1.020 | 2.827 | HCC1806 KIN001-244 0 2 72 |
HCC1806 | KIN001-244 | 2 | 72 | 0.0032 | 11082.0 | 11660.3 | 1643.3 | -2.49 | 0.964 | 0.950 | 2.827 | HCC1806 KIN001-244 0 2 72 |
HCC1806 | KIN001-244 | 2 | 72 | 0.01 | 10733.5 | 11660.3 | 1643.3 | -2.0 | 0.942 | 0.921 | 2.827 | HCC1806 KIN001-244 0 2 72 |
HCC1806 | KIN001-244 | 2 | 72 | 0.032 | 10972.3 | 11660.3 | 1643.3 | -1.49 | 0.957 | 0.941 | 2.827 | HCC1806 KIN001-244 0 2 72 |
HCC1806 | KIN001-244 | 2 | 72 | 0.1 | 11622.0 | 11660.3 | 1643.3 | -1.0 | 0.998 | 0.997 | 2.827 | HCC1806 KIN001-244 0 2 72 |
HCC1806 | KIN001-244 | 2 | 72 | 0.32 | 11461.0 | 11660.3 | 1643.3 | -0.495 | 0.988 | 0.983 | 2.827 | HCC1806 KIN001-244 0 2 72 |
HCC1806 | KIN001-244 | 2 | 72 | 1.0 | 11475.5 | 11660.3 | 1643.3 | 0.0 | 0.989 | 0.984 | 2.827 | HCC1806 KIN001-244 0 2 72 |
HCC1806 | KIN001-244 | 2 | 72 | 3.2 | 11439.0 | 11660.3 | 1643.3 | 0.505 | 0.986 | 0.981 | 2.827 | HCC1806 KIN001-244 0 2 72 |